Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68382-565

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68382-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (0d89802b 2784 4eeb 977c 299ab20fd53e 01)

Chemical structure of metoprolol succinate, showing the molecular components and arrangement of the metoprolol portion and succinate moiety as part of the compound.*

FDA Label Image

Figure (0d89802b 2784 4eeb 977c 299ab20fd53e 02)

A forest plot chart titled 'Results for Subgroups in MERIT-HF' presenting relative risk and 95% confidence intervals for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality or Hospitalization for Heart Failure. The chart compares Metoprolol Succinate versus placebo across various subgroups, including geography (US, Non-US), NYHA class, ejection fraction, ischemic etiology, sex, race, previous myocardial infarction status, diabetes mellitus, hypertension history, and heart rate. The x-axis shows relative risk values with indications favoring Metoprolol Succinate or placebo.*

FDA Label Image

Figure (0d89802b 2784 4eeb 977c 299ab20fd53e 03)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 25 mg strength, oral tablet dosage form. The label states a count of 100 tablets, prescription use only, and identifies Zydus Pharmaceuticals (USA) Inc. as distributor and Zydus Lifesciences Ltd. as manufacturer. It includes storage directions, a warning to keep out of children's reach, and dosage information highlights. The label features the NDC 68382-564-01 and a barcode on a white background with purple accents.*

FDA Label Image

Figure (0d89802b 2784 4eeb 977c 299ab20fd53e 04)

Metoprolol Succinate Extended-Release Tablets USP, 50 mg, in a bottle containing 100 tablets. The label includes the NDC number 68382-565-01 and states the product is Rx only. Manufactured by Zydus Lifesciences Ltd., Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ. The label provides storage instructions and a child-resistant warning.*

FDA Label Image

Figure (0d89802b 2784 4eeb 977c 299ab20fd53e 05)

Label for Metoprolol Succinate Extended-Release Tablets, USP 100 mg by Zydus Pharmaceuticals (USA) Inc. The label shows the extended-release tablets in a package of 100 tablets for prescription use only. It includes storage instructions, a warning to keep out of the reach of children, and manufacturer information for Zydus Lifesciences Ltd., India.*

FDA Label Image

Figure (0d89802b 2784 4eeb 977c 299ab20fd53e 06)

Metoprolol Succinate Extended-Release Tablets, USP 200 mg from Zydus Pharmaceuticals (USA) Inc. The label displays 100 tablets in a child-resistant package with storage instructions at 20° to 25°C. It includes manufacturer information for Zydus Lifesciences Ltd. and distributor details for Zydus Pharmaceuticals (USA) Inc. The label shows NDC 68382-567-01 and specifies prescription-only use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.